APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR OF 2019 PRELIMINARY UNAUDITED FINANCIAL RESULTS AND INTRODUCES FIRST QUARTER OF FISCAL YEAR 2020 FINANCIAL OUTLOOKBy ApyxMedical|2025-12-12T19:39:43+00:00March 16, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RESTATE PREVIOUSLY ISSUED FINANCIAL STATEMENTSBy ApyxMedical|2025-12-12T19:40:08+00:00March 16, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2019 FINANCIAL RESULTS ON MARCH 16, 2020By ApyxMedical|2025-12-12T19:40:31+00:00February 5, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS PRELIMINARY FULL YEAR AND FOURTH QUARTER 2019 REVENUE RESULTSBy ApyxMedical|2025-12-12T19:40:55+00:00January 13, 2020|2020 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES SUBJECT ENROLLMENT INITIATED IN NEW STUDY EVALUATING THE USE OF RENUVION® TECHNOLOGY IN DERMAL RESURFACING PROCEDURESBy ApyxMedical|2025-12-12T19:41:17+00:00December 3, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS THIRD QUARTER OF 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOKBy ApyxMedical|2025-12-12T19:41:43+00:00November 11, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER AND DECEMBERBy ApyxMedical|2025-12-12T19:42:06+00:00November 4, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES SUBJECT ENROLLMENT INITIATED IN STUDY EVALUATING THE USE OF RENUVION® TECHNOLOGY IN SKIN LAXITY PROCEDURES IN THE NECK AND SUBMENTAL REGIONBy ApyxMedical|2025-12-12T19:42:29+00:00October 14, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION RECEIVES 510(K) CLEARANCE FOR THE APYX PLASMA/RF HANDPIECEBy ApyxMedical|2025-12-12T19:43:03+00:00October 14, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON NOVEMBER 11, 2019By ApyxMedical|2025-12-12T19:43:26+00:00September 24, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBER AND OCTOBERBy ApyxMedical|2025-12-12T19:43:47+00:00August 22, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION REPORTS SECOND QUARTER AND FIRST HALF OF 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOKBy ApyxMedical|2025-12-12T19:44:09+00:00August 7, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF MINNIE BAYLOR-HENRY TO THE COMPANY’S BOARD OF DIRECTORSBy ApyxMedical|2025-12-12T19:44:31+00:00August 6, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION RECEIVES 510(K) CLEARANCE FOR NEXT-GENERATION J-PLASMA® PRECISE HANDPIECE DESIGNED FOR LAPAROSCOPIC SURGERYBy ApyxMedical|2025-12-12T19:44:53+00:00August 5, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES NEW ADDITIONS TO CLINICAL AND REGULATORY AFFAIRS TEAMSBy ApyxMedical|2025-12-12T19:45:15+00:00July 31, 2019|2019 Shareholder News, J-Plasma, Renuvion|
APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF FOUR MEMBERS TO ITS MEDICAL ADVISORY BOARDBy ApyxMedical|2025-12-12T19:45:35+00:00July 15, 2019|2019 Shareholder News, J-Plasma, Renuvion|
